M&T Bank’s Alaunos Therapeutics TCRT Stock Holding History

M&T Bank’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-130	Closed	-$235K	–	1999
2015 Q2	$235K	Buy	+130	New	+$202K	﹤0.01%	1663

Other funds holding TCRT

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

M&T Bank's TCRT Position: Q3 2015 in Review

M&T Bank sold out of Alaunos Therapeutics (TCRT) in Q3 2015, closing a stake of 130 shares — an estimated $235K sold.

M&T Bank first reported a position in TCRT in Q2 2015 and held it in 1 quarter. The position peaked at $235K in Q2 2015. 138 funds tracked by Wall St. Rank hold TCRT as of Q3 2015.

M&T Bank reported no remaining Alaunos Therapeutics position as of Q3 2015 after selling out during the quarter.
M&T Bank sold 130 Alaunos Therapeutics shares in Q3 2015, an estimated $235K.
M&T Bank first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 1 quarter.
M&T Bank's Alaunos Therapeutics position peaked at $235K in Q2 2015.
138 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.